argyrotsipi/train-dataset huggingface dataset:
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): As I have said, we will be considering the four-week pilot as part of the Green Paper. We want to see these mental health first-aiders in schools, and as soon as we can give my hon. Friend an exact timetable on the situation Crawley, as well as elsewhere, I am sure that my colleague the Under-Secretary will do so.
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): No, I do not accept that it was a mistake. We need to increase the number of people coming into nursing, and we were turning away far too many who wanted to come into it. The workforce is obviously a huge challenge across the NHS, in primary care—my area—in secondary care and, of course, in mental health, which is why the Secretary of State has said we will create 21,000 new posts by 2021 to support one of the biggest expansions in mental health services in Europe.
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): That is a good point—and one that sits at the centre of my portfolio. GPs are generalists. As the Minister for cancer, I know that there is always criticism of their specialism in that, but, by their very nature, GPs cannot be specialists in everything. That is why the mental health support teams, which are at the heart of the proposal in the Green Paper, are a key part of our strategy, and we expect them to work closely with GPs and the Royal College of General Practitioners to upskill GPs, working within the multi-disciplinary teams, to help young people when they need that help.
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I hope that when the hon. Lady meets that person in her constituency tomorrow she will recognise the good work that is going on and the number of people who are going over and above to deliver the services to children and people. I should also say that one of her responsibilities as a Member of Parliament, as it is ours as Ministers, is to see to it that the sustainability and transformation partnerships in her area collaborate with all the various organisations in her constituency and that the traditional health and social care services are joined up with schools, police, probation services and mental health services, because ultimately it is one NHS.
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I am very aware of the hon. Gentleman’s work on the Westminster Commission on Autism—he has a big event coming up in the next few weeks that I hope to go to. I completely agree with him, which is why it was so welcome that the CQC report highlighted Government proposals such as establishing dedicated mental health support teams in schools.
Mental Health Services: Children and Young People — House of Commons, 2018-03-08
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): That is an excellent point. The NHS is very good at sharing best practice; the challenge comes in implementing it. The report rightly says that there are very good examples of good person-centred care throughout the country. The challenge is to make sure that is rolled out everywhere. I suppose the answer is to focus on the workforce and the investment, and to make sure that we have in place the agreed strategy to take the sector with us and do that.
Salisbury Incident — House of Commons, 2018-03-08
Topic: Defense
Edward Julian Egerton Leigh (Conservative, Centre-right): The circumstantial evidence against Russia is strong—who else would have the motive and the means?—and I will put the same question to the Home Secretary that I put to the Foreign Secretary earlier this week. Those of us who seek to understand Russia know that the only way to preserve peace is through strength. If Russia is behind this, it is a brazen act of war and humiliates our country. I echo the remarks of the junior Defence Minister last week: defence is the first duty of the realm and spending 2% on defence is now not enough.
Salisbury Incident — House of Commons, 2018-03-08
Topic: Health
Amber Rudd (Conservative, Centre-right): Yes. That is a very good point. Quite a number of individuals in Salisbury have been concerned about their health, and have wanted to report concerns about the incident. They have been coming forward and receiving the appropriate treatment and support.
Topical Questions — House of Commons, 2018-02-21
Topic: Health
David Roy Lidington (Conservative, Centre-right): I was pleased to be able to announce that Mr Justice Langstaff will serve as chair for the independent inquiry into the infected blood scandal. He is a highly experienced judge who I am confident will conduct a thorough inquiry. Over the coming weeks, he will be talking to those affected to set comprehensive terms of reference, and the Government will provide him with all the support he needs. [Interruption.]
Engagements — House of Commons, 2018-02-21
Topic: Health
Questions: The people of Willenhall and Bloxwich want to see more police on the streets, and I have lobbied the Police Minister for funds to put more police on the streets. Will the Prime Minister join me in urging the Labour police and crime commissioner to put more police on the streets instead of increasing his budget for back-office staff by £10 million?; My constituent Evelyn Fisher was killed when a car mounted the pavement, with tests done after the incident indicating that the driver had an undiagnosed medical condition that would have needed to be assessed by the Driver and Vehicle Licensing Agency had it been detected beforehand. What view does the Prime Minister take of the current system and rules for ensuring that those who hold driving licences are fit to drive?; De La Rue has been manufacturing and innovating in the UK for nearly 200 years, including at its factory in Westhoughton at the heart of my constituency. It is the only British company that is bidding to produce our new passport, with the other two bidders being French. Will my right hon. Friend commit to doing all she can to support our manufacturers and innovators, and to make our new blue passport truly British?; My constituent, Claire Throssell, suffered terrible tragedy when her two children were murdered by their father in an arson attack at the family home. This brave woman has since dedicated herself to campaigning for victims of domestic violence to receive better protection from the family courts and the various public services concerned. Will the Prime Minister tell us when the domestic violence Bill will be published? Will it be as comprehensive as she promised when she announced the intention to legislate?; I recently visited a memory café in Drighlington Methodist church in my constituency. The café is open to individuals and their carers, and helps to provide support for memory loss. I was touched by the dedication of the volunteers, and I will soon be hosting my own memory surgery, which will give local residents with memory loss the opportunity to speak about issues affecting their lives. Will the Prime Minister take this opportunity to update the House on what the Government are doing to help those with dementia and to congratulate the hard-working carers of those suffering with this progressive condition?
Theresa Mary May (Conservative, Centre-right): I am very happy to join my hon. Friend in congratulating those many carers who are looking after people with dementia, and also volunteers who provide services for people with dementia and their carers. We are working with partners across the health system to ensure that more people with dementia than ever before receive a diagnosis, as well as to raise awareness, to ensure that people get an earlier diagnosis, and to provide the care and support that is needed. I am also pleased to say that there are now 2.3 million dementia friends across the country, and that we are doubling spending on dementia research. I will also ensure that members of the Cabinet are given the dementia friends training.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Sarah James (Wollaston) (Conservative, Centre-right): I welcome the Secretary of State’s statement and his ongoing focus on patient safety, which has added so much to the patient experience. I also welcome the fact that he is clearly representing the voice of patients when learning lessons. Many of those who, courageously, have come forward, including many of my own constituents, have been harmed in the private sector. Will he confirm that all patients, wherever they were treated, will be included within the review and that there will be a focus on clinical governance, not only in the NHS but in the private sector?
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I can absolutely give that assurance. We are considering how to strengthen oversight, because a tragedy is a tragedy wherever it happens, and we should be demanding the highest standards of care throughout our healthcare system. We are particularly considering the issue of data sharing, because often clinicians operate in both the NHS and the private sector, and we want to make sure that we do not have two datasets but that we share data in a way that makes patients safer.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): With respect to the hon. Gentleman, he is being a little uncharitable in describing this as a "review of reviews". We have announced immediate action in each of these three cases—it will happen right away and will be of huge significance in the use of valproate, help for families who think they have suffered as a result of Primodos and the use of mesh. A lot of things are happening right away. These are complex issues, however, and if we are to step back and look at the systemic failures we think have happened, it is important that we ask what changes are needed. That is why we need someone of Baroness Cumberlege’s experience: she has a huge track record of campaigning on women’s issues; she was a Minister at the Department of Health for five years; and she did the "Better Births" review for NHS England in 2015. She is hugely experienced and passionate about patient safety and making sure that the patient voice is heard.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
George William Freeman (Conservative, Centre-right): I welcome the review and the announcement of Baroness Cumberlege as its lead. I am sure the whole House will agree that she is, as the Secretary of State said, highly qualified and trusted. I pay tribute to the many hundreds of thousands of women who have suffered in silence and campaigned so effectively. As the Minister who surprised a few in announcing the Primodos working group, setting up the sodium valproate taskforce, with my right hon. Friend, and brokering the deal on the Saatchi Bill, I have seen the passion and the silent suffering with which so many women have had to live. He is absolutely right that for too long the medical establishment has tended to link arms and act very protectively when challenged, and we need to make sure that the patient voice is put right at the heart of this Will the Secretary of State agree with two points? First, does he agree that it is important that this does not become some legal witch hunt, but starts as a review of the evidence, the science and the clinical data in order to avoid future patient suffering? If it is couched in terms of legal liability, everyone will draw in and resist the sharing of evidence that is so key. Secondly, will he look at training? On mesh, the MHRA has licensed the device, but my understanding is that the problem is often with the training of clinicians in its installing. We need an intelligent healthcare system that uses everyday data to support patient safety.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I would like to put on the record my thanks to my hon. Friend for the work he did as a Minister in my Department that led to the setting up of the expert working group, which I think has taken this issue forward and which he championed. His experience of the life sciences industry was incredibly helpful. I take on board both his points. It is absolutely right that this needs to focus on patient safety and how we put in place processes that help people suffering now and avoid it happening in the future. His point about training is a very good one.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): As the right hon. Gentleman knows—we have had these discussions at the Health Select Committee—this country makes an enormous contribution to medicines regulation across Europe, because of our extensive scientific base, and we very much hope that those links continue.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Caroline Elizabeth Johnson (Conservative, Centre-right): I welcome the review of the yellow card process. The first responsibility of the doctor is always to do no harm, and every doctor, when making any prescribing decision, always balances the potential improvement in patient care with the known risks. Sometimes, as more drugs are given to more people, rarer side effects will come through, and the improvements in the yellow card system will mean that those are identified earlier My other point is about Roaccutane. It is a drug given to treat acne but is known to be exceptionally toxic in pregnancy. I remember from my time working in dermatology that to get a prescription women had to attend monthly and have a negative pregnancy test before the next prescription was issued. I wonder whether that approach could be more widespread in the prescription of some of these drugs, which do provide some benefit but are known to be harmful.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): My hon. Friend’s question demonstrates how useful it is to have people with medical experience in the House. To be honest, I am slightly overwhelmed by the detail in her question, but her broad point is absolutely right. The difficulty with the issues today is how much they affect women, particularly pregnant women. Through the review, we want to establish whether we are doing less well than we should on women’s health issues. Given that Baroness Cumberlege has done more campaigning on women’s health issues than pretty much anyone else in either House, I think she is the right person to take the review forward. My hon. Friend is absolutely right about strengthening the protections for pregnant women.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): The hon. Lady and I may not agree on every part of my statement, but I thank her for her campaigning on this issue, and for the voice that she has given to thousands of women who believe that they have suffered badly as a result of Primodos. The things for which she has asked were not ruled out in the statement; in fact, what I have announced will create a process during which someone will look very carefully at the issue The hon. Lady has made some very serious allegations, and it is absolutely her right to do so as a Member of this House, but they differ from the conclusions reached by the expert working group. It is precisely because of that disagreement that we have asked Baroness Cumberlege to look carefully at the issue and form her own view of the right way forward. However, I assure the hon. Lady that regulatory failures are at the front of our minds, and we are absolutely determined to ensure that victims’ voices are heard.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): I thank the Secretary of State for the compassionate tone that he has struck today, and for taking account of the years for which many campaigners, such as Janet Williams and Emma Murphy, have tried to make their voices heard, on valproate in particular. If, following the review, various medicines or medical devices are found to be unsafe—or, indeed, to have been taken unsafely—will there be legal consequences for the regulators who should have acted differently?
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): The simple answer to that question is yes: there are legal consequences for regulators who have failed. In that instance, it would be the responsibility of the Government, or of the drugs companies who failed in their responsibility to inform patients of the dangers of taking drugs. The priority is to establish the facts. Some of those are clear now, but some are not, and that is why I think that the review will help us.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I can give the hon. Gentleman an absolute assurance that she will do so. In the case of valproate it is very clear what the next steps should be, because there is no dispute over the science. When there is controversy over the science—and I appreciate how distressing that is for the families involved—the first thing we must do is establish the truth of the situation, and that is why we have given Baroness Cumberlege a free hand to look at the whole issue.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Helen Olivia Bicknell Whately (Conservative, Centre-right): I welcome the statement, which is consistent with my right hon. Friend’s track record of driving the NHS to stop causing harm to patients. May I ask him to continue to focus on encouraging, requiring and supporting all healthcare professionals to make the shift from a defensive to a learning mindset, so that they listen and learn not just from NHS experience, but from patients as well?
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): My hon. Friend, who has huge experience in healthcare, is right to say that at the heart of dealing with these very complex issues is the need for us to be careful not to inadvertently encourage a culture of defensive medicine. If doctors feel unable to be open about mistakes that may have happened because they are worried about legal consequences, we will not benefit from the learning that is so incredibly important, and one of the purposes of the review is to ensure that we support that open learning culture.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I totally respect the right hon. Gentleman for airing his constituents’ concerns, but, as he will know from my answers to earlier questions, the difficulty in the case of Primodos—and this is incredibly distressing for the families involved—is that scientists do not agree about the issue, and as a result we do, unfortunately, find ourselves having to review what has happened. The review conducted by the expert working group was our first attempt. We are now giving Baroness Cumberlege a free hand to consider that and any other evidence that has come to light, and to draw her own conclusions.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Huw William Merriman (Conservative, Centre-right): Just an hour ago I met my constituent Carol Short and Emma Friedmann, a constituent of the hon. Member for Leicester South (Jonathan Ashworth), to discuss the next stage of the valproate campaign, but because of the statement, that meeting was adjourned. I am happy that they are now in the Chamber, and I am sure that they are pleased to hear about the review Is it possible to ensure that GPs are giving out the excellent advice that the Medicines and Healthcare products Regulatory Agency has put together? I am sorry to say that it seems that far too many are not, and there appear to be no regulatory sanctions to ensure that they do.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I can give my hon. Friend the assurance for which he has asked. We have announced today that we are improving the system of alerting both general practices and community pharmacies to ensure that the right advice is given and the right safeguards are in place, so that people who are pregnant or might become pregnant do not take a medicine that is very powerful and very effective in the right circumstances, but incredibly dangerous in the wrong ones.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Andrew Edmund Armstrong Selous (Conservative, Centre-right): I have a constituent whose quality of life has been completely ruined by a surgical mesh implant. What reassurance can we have that the Cumberlege review will ensure that the voice of the patient is listened to much more quickly in future, so that when things go wrong, we limit the number of patients who suffer the type of harm that we have heard about this morning?
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): That is the right question to ask. I suggested in the statement that we might need a patients’ champion whose job would be to collect the experiences and views of patients who think that they may have suffered as a result of medicine or medical devices. However, we want Baroness Cumberlege to look at the issue in much more detail. The central point is that if we are to avoid the agonies experienced by my hon. Friend’s constituents, the patient’s voice needs to be as strong as the clinician’s in discussions about the efficacy of medicines or medical devices. That clearly has not been happening to date, but I think that we are moving away from the paternalist system that has operated in the past, and the review will constitute a further step in that direction.
Medicines and Medical Devices Safety Review — House of Commons, 2018-02-21
Topic: Health
Simon James Hoare (Conservative, Centre-right): With their incredibly moving stories, my constituents Karen, a victim of vaginal mesh, and Angie, with Primodos, will have listened intently to what my right hon. Friend has said. May I underscore a point made by colleagues on both sides of the House? There are two key issues apart from the Cumberlege review. First, we must ensure that our medics, from med school up, realise that they are not gods, because that is how many patients feel when they have to deal with them and their concerns are too easily dismissed. That needs to change from the bottom up. Secondly, my right hon. Friend made the point that this is an issue not just for the NHS but for private health care too. It involves patients living in all quarters of the United Kingdom. How will this learning, and the learning of the review, spread, while respecting the devolved Assemblies, in those regions where the health service is not under the control of my right hon. Friend?